Matches in SemOpenAlex for { <https://semopenalex.org/work/W2588165975> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W2588165975 endingPage "vi80" @default.
- W2588165975 startingPage "vi80" @default.
- W2588165975 abstract "Even though SMARCB1 mutations are the only genetic aberrations in atypical teratoid / rhabdoid tumors (ATRT), we recently demonstrated that distinct molecular subgroups exist. However, the broad effects of SMARCB1loss on the epigenetic landscape of these three subgroups remain unclear. We performed ChIPsequencing for six active and repressive histone marks (H3K4me1, H3K4me3, H3K27me3, H3K27Ac, H3K9me3, H3K36me3) and EZH2 in 11 primary AT/RT, encompassing all three subgroups. DNA-methylation and gene expression data were available for all cases and integrated into the analysis. The overall chromatin analysis, compared to non-neoplastic brain tissues, revealed that for all three subgroups a high percentage of the AT/RT genome is either in a quiescent or polycomb repressed state and a significantly lower percentage of the AT/RT genome is in an active enhancer state, suggesting a subgroup independent effect of SMARCB1loss in these tumors. There is, however, a clear difference between the subgroups regarding the distribution of specific enhancer and repressive marks. Surprisingly, we discovered a dual role of EZH2, not only associated with repressed chromatin, but also with active promoters. SMARCB1 ChIP-seq analyses in normal brain suggested that in AT/RT a transition from active chromatin states to either bivalent or repressed chromatin states at SMARCB1 binding sites takes place. Due to this switch at SMARCB1 binding sites, we detected several tumor suppressors transcriptionally repressed. These may play a role in AT/RT tumorigenesis. Our comprehensive study of histone marks in this gentically homogeneous but epigenetically heterogeneous disease enabled us to not only shed a light on the chromatin landscape of these tumors but also on the potentially tumorigenic consequences of SMARCB1 loss. In addition, the dual role of EZH2 in these tumors further enhances the importance of this molecule as a therapeutic target and underlines the importance of clinically targeting this molecule." @default.
- W2588165975 created "2017-02-24" @default.
- W2588165975 creator A5009273251 @default.
- W2588165975 creator A5024124953 @default.
- W2588165975 creator A5033551454 @default.
- W2588165975 creator A5039864062 @default.
- W2588165975 creator A5041096535 @default.
- W2588165975 creator A5043333166 @default.
- W2588165975 creator A5049671490 @default.
- W2588165975 creator A5052289702 @default.
- W2588165975 creator A5057994815 @default.
- W2588165975 creator A5069803667 @default.
- W2588165975 creator A5070844726 @default.
- W2588165975 creator A5073211182 @default.
- W2588165975 date "2016-11-01" @default.
- W2588165975 modified "2023-09-23" @default.
- W2588165975 title "GENT-28. THE EPIGENETIC LANDSCAPE OF ATYPICAL TERATOID/ RHABDOID TUMORS REVEALS A REPRESSED METHYLOME AND EPIGENETIC SWITCHES AT SMARCB1 BINDING SITES" @default.
- W2588165975 doi "https://doi.org/10.1093/neuonc/now212.334" @default.
- W2588165975 hasPublicationYear "2016" @default.
- W2588165975 type Work @default.
- W2588165975 sameAs 2588165975 @default.
- W2588165975 citedByCount "0" @default.
- W2588165975 crossrefType "journal-article" @default.
- W2588165975 hasAuthorship W2588165975A5009273251 @default.
- W2588165975 hasAuthorship W2588165975A5024124953 @default.
- W2588165975 hasAuthorship W2588165975A5033551454 @default.
- W2588165975 hasAuthorship W2588165975A5039864062 @default.
- W2588165975 hasAuthorship W2588165975A5041096535 @default.
- W2588165975 hasAuthorship W2588165975A5043333166 @default.
- W2588165975 hasAuthorship W2588165975A5049671490 @default.
- W2588165975 hasAuthorship W2588165975A5052289702 @default.
- W2588165975 hasAuthorship W2588165975A5057994815 @default.
- W2588165975 hasAuthorship W2588165975A5069803667 @default.
- W2588165975 hasAuthorship W2588165975A5070844726 @default.
- W2588165975 hasAuthorship W2588165975A5073211182 @default.
- W2588165975 hasBestOaLocation W25881659751 @default.
- W2588165975 hasConcept C101762097 @default.
- W2588165975 hasConcept C104317684 @default.
- W2588165975 hasConcept C111936080 @default.
- W2588165975 hasConcept C121912465 @default.
- W2588165975 hasConcept C150194340 @default.
- W2588165975 hasConcept C167227067 @default.
- W2588165975 hasConcept C177450382 @default.
- W2588165975 hasConcept C190727270 @default.
- W2588165975 hasConcept C2778467961 @default.
- W2588165975 hasConcept C2780789225 @default.
- W2588165975 hasConcept C2780914512 @default.
- W2588165975 hasConcept C41091548 @default.
- W2588165975 hasConcept C50171091 @default.
- W2588165975 hasConcept C502942594 @default.
- W2588165975 hasConcept C54355233 @default.
- W2588165975 hasConcept C555283112 @default.
- W2588165975 hasConcept C64927066 @default.
- W2588165975 hasConcept C83640560 @default.
- W2588165975 hasConcept C86803240 @default.
- W2588165975 hasConceptScore W2588165975C101762097 @default.
- W2588165975 hasConceptScore W2588165975C104317684 @default.
- W2588165975 hasConceptScore W2588165975C111936080 @default.
- W2588165975 hasConceptScore W2588165975C121912465 @default.
- W2588165975 hasConceptScore W2588165975C150194340 @default.
- W2588165975 hasConceptScore W2588165975C167227067 @default.
- W2588165975 hasConceptScore W2588165975C177450382 @default.
- W2588165975 hasConceptScore W2588165975C190727270 @default.
- W2588165975 hasConceptScore W2588165975C2778467961 @default.
- W2588165975 hasConceptScore W2588165975C2780789225 @default.
- W2588165975 hasConceptScore W2588165975C2780914512 @default.
- W2588165975 hasConceptScore W2588165975C41091548 @default.
- W2588165975 hasConceptScore W2588165975C50171091 @default.
- W2588165975 hasConceptScore W2588165975C502942594 @default.
- W2588165975 hasConceptScore W2588165975C54355233 @default.
- W2588165975 hasConceptScore W2588165975C555283112 @default.
- W2588165975 hasConceptScore W2588165975C64927066 @default.
- W2588165975 hasConceptScore W2588165975C83640560 @default.
- W2588165975 hasConceptScore W2588165975C86803240 @default.
- W2588165975 hasIssue "suppl_6" @default.
- W2588165975 hasLocation W25881659751 @default.
- W2588165975 hasOpenAccess W2588165975 @default.
- W2588165975 hasPrimaryLocation W25881659751 @default.
- W2588165975 hasRelatedWork W2105682042 @default.
- W2588165975 hasRelatedWork W2222106441 @default.
- W2588165975 hasRelatedWork W2588165975 @default.
- W2588165975 hasRelatedWork W2786789123 @default.
- W2588165975 hasRelatedWork W2804530192 @default.
- W2588165975 hasRelatedWork W2804716665 @default.
- W2588165975 hasRelatedWork W4296322320 @default.
- W2588165975 hasRelatedWork W4322754247 @default.
- W2588165975 hasRelatedWork W4361228084 @default.
- W2588165975 hasRelatedWork W4378576129 @default.
- W2588165975 hasVolume "18" @default.
- W2588165975 isParatext "false" @default.
- W2588165975 isRetracted "false" @default.
- W2588165975 magId "2588165975" @default.
- W2588165975 workType "article" @default.